Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 12, 2026 PDSB A 300,000 · · 300,000 Direct · Acquired (price as of 2026-10-05)
June 12, 2025 PDSB A 150,000 · · 150,000 Direct · Acquired (price as of 2026-10-05)
Jan. 22, 2024 PDSB A 200,000 · · 200,000 Direct · Acquired (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 12, 2026 PDSB Employee Stock Option (Right to Buy) Common Stock (300,000) $0.98 Jan. 12, 2036 300,000 Acquired
June 12, 2025 PDSB Employee Stock Option (Right to Buy) Common Stock (150,000) $1.79 June 12, 2035 150,000 Acquired
Jan. 22, 2024 PDSB Employee Stock Option (Right to Buy) Common Stock (200,000) $4.49 Jan. 22, 2034 200,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PDSB

M.D.(3)Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $463,500 · · · · · $20,318 $677,318
2024 $426,346 $45,000 · · · · $14,250 $1,325,596

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.